Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dev Center BiotechnologyfiledCriticalDev Center Biotechnology
Priority to TW81105934ApriorityCriticalpatent/TW288047B/zh
Application grantedgrantedCritical
Publication of TW288047BpublicationCriticalpatent/TW288047B/zh
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Peptides Or Proteins
(AREA)
TW81105934A1992-07-281992-07-28Method for producing the replication activator (ZEBRA) of Taiwan strain epstein-barr virus as antigen protein
TW288047B
(en)
Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
The role of herpes simplex virus ribonucleotide reductase small subunit carboxyl terminus in subunit interaction and formation of iron-tyrosyl center structure.
Induction by chemically modified actin derivatives of antibody specificity: A relation between modified sites and antibody interactions with monomeric and filamentous actins